Karl

Karl Gibson, PhD

Head of Medicinal Chemistry

Orexia Therapeutics

Karl Gibson, PhD, serves as Head of Medicinal Chemistry at Orexia Therapeutics. Prior to joining Orexia, Karl spent five years as a Medicinal Chemist at Merck & Co., Inc. Neuroscience Research Center followed by nine years at Pfizer, leading Medicinal Chemistry teams across the Pain, Urology and Infectious Disease therapeutic areas.

In 2011, Karl co-founded Sandexis Medicinal Chemistry. Since then, he has provided Medicinal Chemistry leadership and design to a number of biotech companies and programs.

Karl obtained his PhD in Chemistry from the University of Cambridge.

Read more here about Orexia Therapeutics

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser

×